Synthego

About:

Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.

Website: http://www.synthego.com

Twitter/X: synthego

Top Investors: Menlo Ventures, RA Capital Management, Wellington Management, Intel Capital, Moore Strategic Ventures

Description:

Synthego is a genome engineering company that enables the acceleration of life science research and development in the pursuit of improved human health. The company leverages machine learning, automation, and gene editing to build platforms for science at scale. With its foundations in engineering disciplines, the company’s full-stack platform vertically integrates proprietary hardware, software, bioinformatics, chemistries, and molecular biology to advance both basic research and therapeutic development programs. By providing both commercial and academic researchers and therapeutic developers with unprecedented access to cutting-edge genome engineering, Synthego is at the forefront of innovation, accelerating the development of truly engineered biology. The company was founded in 2012 and is based in Redwood City, California.